Advanced Biomedical Technologies, Inc.
ABMTOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$50000
P/E Ratio—
52W High$0.0005
52W Low$0.0001
Advanced Biomedical Technologies, Inc. (ABMT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABMT · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-10 | 2021-10 | 2020-10 | 2019-10 | 2018-10 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.27M | $0.17M | $0.12M | $0.01M | $0.00M |
| Cost of Revenue | $0.05M | $0.08M | $0.05M | $0.01M | $0.00M |
| Gross Profit | $0.22M | $0.09M | $0.07M | $0.00M | $0.00M |
| Gross Margin %(computed) | 81.88% | 54.50% | 58.07% | 34.84% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.19M | $0.23M | $0.18M | $0.26M | $0.06M |
| G&A Expenses | $0.00M | $0.00M | $0.28M | $0.32M | $0.56M |
| Total Operating Expenses | $0.40M | $0.49M | $0.52M | $0.61M | $0.63M |
| Operating Income | ($0.18M) | ($0.39M) | ($0.45M) | ($0.60M) | ($0.63M) |
| Operating Margin %(computed) | -66.38% | -230.65% | -361.38% | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.33M | $0.32M | $0.33M | $0.33M | $0.30M |
| Income Before Tax | ($0.52M) | ($0.73M) | ($0.67M) | ($0.95M) | ($0.95M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.52M) | ($0.73M) | ($0.67M) | ($0.95M) | ($0.95M) |
| Net Margin %(computed) | -190.22% | -426.10% | -543.75% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Wtd Avg Shares | 70.61M | 70.24M | 69.94M | 69.63M | 69.38M |
| EBITDA | ($0.17M) | ($0.37M) | ($0.28M) | ($0.60M) | ($0.64M) |
| EBITDA Margin %(computed) | -61.26% | -214.63% | -228.74% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Advanced Biomedical Technologies, Inc. data
About Advanced Biomedical Technologies, Inc. (ABMT) Income Statement
Advanced Biomedical Technologies, Inc. (ABMT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, ABMT reported revenue of $0.00B, gross profit of $0.00B (gross margin 81.88%), and net income of ($0.00B) — a net profit margin of -190.22%.
Frequently asked questions
ABMT · 4 questionsAdvanced Biomedical Technologies, Inc. (ABMT) reported revenue of $0.00B for 2022, up 58.3% year-over-year.
ABMT revenueABMT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09